BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $43,797,000 | -7.0% | 545,822 | -6.8% | 0.13% | -18.2% |
| Q3 2020 | $47,100,000 | -8.6% | 585,677 | -2.2% | 0.16% | -16.3% |
| Q2 2020 | $51,546,000 | +4.9% | 598,668 | -1.1% | 0.19% | -12.4% |
| Q1 2020 | $49,135,000 | -1.9% | 605,175 | +1.0% | 0.22% | +20.6% |
| Q4 2019 | $50,089,000 | -6.8% | 599,011 | -2.5% | 0.18% | -15.1% |
| Q3 2019 | $53,740,000 | +13.5% | 614,378 | +6.3% | 0.21% | +9.8% |
| Q2 2019 | $47,340,000 | -6.2% | 578,015 | -6.8% | 0.19% | -11.5% |
| Q1 2019 | $50,454,000 | +27.1% | 620,509 | +2.8% | 0.22% | +9.0% |
| Q4 2018 | $39,711,000 | -36.6% | 603,322 | -25.8% | 0.20% | -27.8% |
| Q3 2018 | $62,673,000 | +5.0% | 812,986 | +0.5% | 0.28% | -3.1% |
| Q2 2018 | $59,716,000 | +2.8% | 808,726 | -9.4% | 0.29% | -1.0% |
| Q1 2018 | $58,087,000 | -8.9% | 893,098 | -9.5% | 0.29% | -10.8% |
| Q4 2017 | $63,792,000 | +3.7% | 986,872 | +0.6% | 0.32% | -6.6% |
| Q3 2017 | $61,531,000 | -1.1% | 980,571 | -4.6% | 0.35% | -8.9% |
| Q2 2017 | $62,194,000 | +21.1% | 1,027,324 | +3.7% | 0.38% | +8.5% |
| Q1 2017 | $51,366,000 | +185.1% | 990,480 | +143.7% | 0.35% | +154.3% |
| Q4 2016 | $18,019,000 | +24.8% | 406,390 | +34.0% | 0.14% | +32.7% |
| Q3 2016 | $14,436,000 | +45.6% | 303,276 | +38.3% | 0.10% | +35.1% |
| Q2 2016 | $9,916,000 | +20.2% | 219,277 | +9.2% | 0.08% | +8.5% |
| Q1 2016 | $8,251,000 | +30.4% | 200,869 | +21.1% | 0.07% | +22.4% |
| Q4 2015 | $6,326,000 | +8.1% | 165,832 | -6.9% | 0.06% | -3.3% |
| Q3 2015 | $5,851,000 | -47.9% | 178,103 | +10.8% | 0.06% | -48.3% |
| Q2 2015 | $11,240,000 | +17.3% | 160,730 | +14.9% | 0.12% | +8.4% |
| Q1 2015 | $9,581,000 | -5.6% | 139,865 | +1.0% | 0.11% | -14.4% |
| Q4 2014 | $10,150,000 | -0.6% | 138,485 | -2.6% | 0.12% | -9.4% |
| Q3 2014 | $10,208,000 | +7.3% | 142,234 | +8.1% | 0.14% | 0.0% |
| Q2 2014 | $9,514,000 | +7.0% | 131,586 | +8.9% | 0.14% | +10.4% |
| Q1 2014 | $8,892,000 | +21.0% | 120,842 | +14.4% | 0.12% | +9.6% |
| Q4 2013 | $7,346,000 | -5.0% | 105,623 | -10.3% | 0.11% | -23.5% |
| Q3 2013 | $7,732,000 | +9.9% | 117,700 | +15.9% | 0.15% | -10.8% |
| Q2 2013 | $7,033,000 | – | 101,534 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |